261 filings
Page 11 of 14
8-K
okp0pwx2tjsgpog9
16 Mar 16
Departure of Directors or Certain Officers
12:00am
S-8
yro3l tntg
29 Feb 16
Registration of securities for employees
12:00am
8-K
281xe
24 Feb 16
Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
12:00am
8-K
7pe8qzxd0p
13 Jan 16
Other Events
12:00am
424B5
2k26 pcdq3
7 Jan 16
Prospectus supplement for primary offering
12:00am
8-K
ej3b 4ktm264lye
7 Jan 16
Sage Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
424B5
i0zvfevgk aau
5 Jan 16
Prospectus supplement for primary offering
12:00am
S-3ASR
w3cea
5 Jan 16
Automatic shelf registration
12:00am
CT ORDER
3s4gmv6axec
16 Dec 15
Confidential treatment order
12:00am
8-K
hqxwl
16 Dec 15
SAGE Updates Guidance for Top-Line Results of Phase 3 STATUS Trial of SAGE-547
12:00am
CT ORDER
dg9cqzn05t0808zfok
16 Dec 15
Confidential treatment order
12:00am
8-K
j5cw9f1a
5 Nov 15
SAGE Announces Third Quarter 2015 Financial Results and Recent
12:00am
8-K
l6xrozqarlun6kcjy1
6 Oct 15
SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217
12:00am
8-K
kaftwv stoxz
12 Aug 15
SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress
12:00am
8-K
io8qmla
3 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am